- Progressed from feasibility and prototype testing to the optimization stage for its Covid-19 antigen rapid response test;
- Commenced work with two, third-party laboratories to prepare validation protocols;
- Signed a memorandum of understanding to manufacture its test with a second contract manufacturer in North America;
- Accepted pre-orders for a further 1,250,000 of the Company’s antigen detecting, rapid-response test; and
- Secured approval for its common shares to trade on the OTCQB Marketplace under the symbol “SNANF” at the opening of trading today, April 13, 2020. The Company continues to trade on the Canadian Securities Exchange under “SONA”.